Genetic deficiency of ADAM10 in intestinal stem cells drastically reduced colonic and small intestinal adenoma formation in mice with biallelic loss of APC which was linked to the absence of Notch signalling [75], indicating that ADAM10 is a potential attractive target for intestinal cancer therapy (Figure 2b). Here, ADAM10 is linked to intestinal cancer.